X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2846) 2846
Publication (209) 209
Book Review (47) 47
Book Chapter (31) 31
Web Resource (9) 9
Magazine Article (6) 6
Dissertation (5) 5
Newspaper Article (5) 5
Book / eBook (3) 3
Conference Proceeding (2) 2
Newsletter (2) 2
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
teriparatide (1922) 1922
humans (1686) 1686
osteoporosis (1356) 1356
female (1226) 1226
index medicus (1041) 1041
endocrinology & metabolism (911) 911
animals (858) 858
teriparatide - therapeutic use (783) 783
postmenopausal women (755) 755
male (716) 716
bone density conservation agents - therapeutic use (691) 691
parathyroid hormone (626) 626
aged (619) 619
osteoporosis - drug therapy (571) 571
middle aged (569) 569
bone density - drug effects (537) 537
rats (507) 507
orthopedics (491) 491
parathyroid hormone - pharmacology (490) 490
fractures (482) 482
alendronate (446) 446
bone-mineral density (431) 431
peptide fragments - pharmacology (425) 425
teriparatide - pharmacology (383) 383
osteoporosis, postmenopausal - drug therapy (381) 381
teriparatide - administration & dosage (365) 365
parathyroid-hormone (363) 363
medicine & public health (319) 319
bisphosphonates (318) 318
bone density (309) 309
endocrinology (276) 276
aged, 80 and over (274) 274
parathyroid-hormone 1-34 (274) 274
bone density conservation agents - administration & dosage (270) 270
rheumatology (269) 269
drug therapy (255) 255
bone mineral density (252) 252
therapy (250) 250
bones (249) 249
treatment outcome (246) 246
denosumab (243) 243
density (231) 231
adult (230) 230
diphosphonates - therapeutic use (226) 226
risk factors (225) 225
women (225) 225
pth (206) 206
bone and bones - drug effects (204) 204
bone density conservation agents - pharmacology (203) 203
care and treatment (197) 197
bone (187) 187
teriparatide - adverse effects (187) 187
bone density conservation agents - adverse effects (183) 183
risk (182) 182
medicine, general & internal (181) 181
fracture (180) 180
postmenopausal osteoporosis (178) 178
research (171) 171
analysis (170) 170
mineral density (170) 170
mice (168) 168
parathyroid hormone - therapeutic use (160) 160
time factors (153) 153
bone and bones - metabolism (150) 150
dose-response relationship, drug (150) 150
health aspects (150) 150
rats, sprague-dawley (146) 146
pharmacology & pharmacy (144) 144
bone remodeling - drug effects (142) 142
zoledronic acid (141) 141
fractures, bone - prevention & control (140) 140
prevention (140) 140
calcium (139) 139
calcium - blood (138) 138
vertebral fractures (138) 138
osteogenesis - drug effects (137) 137
calcium - metabolism (132) 132
drug therapy, combination (129) 129
medicine, research & experimental (129) 129
vitamin d (126) 126
injections, subcutaneous (125) 125
surgery (125) 125
vertebral fracture (125) 125
cells, cultured (123) 123
drug administration schedule (122) 122
osteoporosis - complications (122) 122
parathyroid hormone - administration & dosage (121) 121
abridged index medicus (117) 117
mass (117) 117
osteoporosis - physiopathology (117) 117
alendronate - therapeutic use (114) 114
osteoblasts - drug effects (114) 114
parathyroid hormone-related protein (111) 111
bisphosphonate (110) 110
ovariectomy (109) 109
strontium ranelate (109) 109
bone resorption (105) 105
cell biology (105) 105
cyclic amp - metabolism (105) 105
kinetics (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2620) 2620
Japanese (73) 73
German (57) 57
French (47) 47
Spanish (28) 28
Chinese (16) 16
Turkish (12) 12
Korean (8) 8
Italian (7) 7
Czech (6) 6
Danish (6) 6
Dutch (4) 4
Hungarian (4) 4
Polish (4) 4
Croatian (3) 3
Portuguese (3) 3
Russian (3) 3
Slovenian (2) 2
Belarusian (1) 1
Finnish (1) 1
Norwegian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that... 
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | ALENDRONATE | WOMEN | FRACTURE | BISPHOSPHONATES | THERAPY | CANCELLOUS BONE | MASS | ENDOCRINOLOGY & METABOLISM | PROXIMAL FEMUR | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood
Journal Article
Osteoporosis International, ISSN 0937-941X, 3/2019, Volume 30, Issue 3, pp. 675 - 683
Journal Article
Osteoporosis International, ISSN 0937-941X, 3/2014, Volume 25, Issue 3, pp. 1173 - 1180
Changes in bone turnover markers with weekly 56.5 μg teriparatide injections for 24 weeks were investigated in women with osteoporosis. Changes in bone... 
Bone resorption | Human | Bone formation | Medicine & Public Health | Orthopedics | Rheumatology | Calcium metabolism | Endocrinology | Teriparatide | STIMULATION | DOWN-REGULATION | OSTEOPROGENITOR CELLS | MINERAL DENSITY | THERAPY | REDUCTION | VERTEBRAL FRACTURE RISK | ENDOCRINOLOGY & METABOLISM | PARATHYROID-HORMONE PTH | DIFFERENTIATION | RECEPTORS | Teriparatide - therapeutic use | Humans | Middle Aged | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Calcium - blood | Osteocalcin - blood | Injections, Subcutaneous | Female | Lumbar Vertebrae - physiopathology | Teriparatide - pharmacology | Bone Resorption - blood | Drug Administration Schedule | Teriparatide - administration & dosage | Teriparatide - blood | Bone Density Conservation Agents - therapeutic use | Biomarkers - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Bone Density Conservation Agents - blood | Bone Resorption - prevention & control | Bone Density - drug effects | Osteoporosis, Postmenopausal - blood | Osteoporosis, Postmenopausal - physiopathology | Aged | Physiological aspects | Osteoporosis | Postmenopausal women | Research | Bone regeneration | Women | Endocrine therapy | Bones | Calcium | Metabolism | Original
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2001, Volume 344, Issue 19, pp. 1434 - 1441
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 1/2011, Volume 28, Issue 1, pp. 159 - 165
Journal Article
Journal Article